Maurizio Recanatini

Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome:  Insights from a CoMFA Study of HERG K⁺ Channel Blockers

Andrea Cavalli, Elisabetta Poluzzi, Fabrizio De Ponti et al. · Journal of Medicinal Chemistry · 2002 · 383 citations · Full text

Molecular Pharmacology, Channelopathies, Long Qt Syndrome +14

3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation:  A Dual Function Lead for Alzheimer's Disease Therapy

Lorna Piazzi, Angela Rampa, Alessandra Bisi et al. · Journal of Medicinal Chemistry · 2003 · 263 citations · Full text

Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer’s Disease

María Laura Bolognesi, Andrea Cavalli, Luca Valgimigli et al. · Journal of Medicinal Chemistry · 2007 · 254 citations · Full text

Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds

Lorna Piazzi, Andrea Cavalli, Francesco Colizzi et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 211 citations · Full text

Medicinal Chemistry, Neurodegenerative Diseases, Alzheimer's Disease +11

Galloflavin (CAS 568‐80‐9): A Novel Inhibitor of Lactate Dehydrogenase

Marcella Manerba, Marina Vettraino, L. Fiume et al. · ChemMedChem · 2011 · 190 citations · Full text

Molecular Pharmacology, Metabolic Pathways, Glycolysis Inhibitors +15